Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T Cells through the ICOSL/ICOS axis

Clinical Immunology

Volumn 142, Issue 3, 2012, Pages 269-279

  Nie, Xiaomeng ^a   Cai, Gang ^b   Zhang, Weiwei ^a   Wang, Huaizhou ^a   Wu, Beiying ^b   Li, Qiang ^a   Shen, Qian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

ICOS; Interleukin 10; ; Mast cell; ; Regulatory t cells;

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE T CELL COSTIMULATOR LIGAND; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; IN VITRO STUDY; INFLAMMATION; LUNG LAVAGE; MALE; MAST CELL; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTIVE IMMUNITY; ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; INDUCIBLE T-CELL CO-STIMULATOR LIGAND; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; NF-KAPPA B; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 4;

EID: 84857364650     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.11.001     Document Type: Article

References (26)

1. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 2008, 8:478-486.
2. Sayed B.A., Christy A., Quirion M.R., Brown M.A. The master switch: the role of mast cells in autoimmunity and tolerance. Annu. Rev. Immunol. 2008, 26:705-739.
3. Frossi B., De Carli M., Pucillo C. The mast cell: an antenna of the microenviroment that directs the immune response. J. Leukoc. Biol. 2004, 75:579-585.
4. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 2005, 6:135-142.
5. Mazzoni A., Siraganian R.P., Leifer C.A., Segal D.M. Dendritic cell modification by mast cells controls the Th1/Th2 balance in responding T cells. J. Immunol. 2006, 177:3577-3581.
6. Piconese S., Gri G., Tripodo C., et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 2009, 114:2639-2648.
7. Merluzzi S., Frossi B., Gri G., Parusso S., Tripodo C., Pucillo C. Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells. Blood 2010, 115:2810-2817.
8. Dietrich N., Rohde M., Geffers R., Kröger A., Hauser H., Weiss S., Gekara N.O. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8748-8753.
9. Takenaka H., Ushio H., Niyonsaba F., Jayawardana S.T., Hajime S., Ikeda S., Ogawa H., Okumura K. Synergistic augmentation of inflammatory cytokine productions from murine mast cells by monomeric IgE and toll-like receptor ligands. Biochem. Biophys. Res. Commun. 2010, 391:471-476.
10. Hauber H.P., Karp D., Goldmann T., Vollmer E., Zabel P. Comparison of the effect of LPS and PAM3 on ventilated lungs. BMC Pulm. Med. 2010, 10:20.
11. Li Y., Heuser J.S., Kosanke S.D., Hemric M., Cunningham M.W. Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells. Am. J. Pathol. 2005, 167:5-15.
12. Cai G., Wang H., Qin Q., Zhang J., Zhu Z., Liu M., Shen Q. Amelioration of myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells. Cardiovasc. Res. 2009, 84:425-433.
13. Grimbaldeston M.A., Nakae S., Kalesnikoff J., Tsai M., Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 2007, 8:1095-1104.
14. Doyle S.L., O'Neill L.A. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 2006, 72:1102-1113.
15. Supajatura V., Ushio H., Nakao A., Okumura K., Ra C., Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 2001, 167:2250-2256.
16. Fujio K., Okamura T., Yamamoto K. The family of IL-10-secreting CD4+ T cells. Adv. Immunol. 2010, 105:99-130.
17. Ito T., Yang M., Wang Y.H., et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007, 204:105-115.
18. Jankovic D., Kugler D.G., Sher A. IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol. 2010, 3:239-246.
19. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., Galli S.J. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 2006, 176:2238-2248.
20. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999, 397:263-266.
21. Simpson T.R., Quezada S.A., Allison J.P. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr. Opin. Immunol. 2010, 22:326-332.
22. Dong C., Nurieva R.I., Prasad D.V. Immune regulation by novel costimulatory molecules. Immunol. Res. 2003, 28:39-48.
23. Akbari O., Freeman G.J., Meyer E.H., et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 2002, 8:1024-1032.
24. Vermeiren J., Ceuppens J.L., Van Ghelue M., et al. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regualatory cell activation. J. Immunol. 2004, 172:5371-5378.
25. Miyamoto K., Kingsley C.I., Zhang X., et al. The ICOS molecule plays a crucial role in the development of mucosal tolerance. J. Immunol. 2005, 175:7341-7347.
26. Warnatz K., Bossaller L., Salzer U., et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 2006, 107:3045-3052.